Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma

Decera Clinical Education Oncology Podcast · Aug 31, 2020 · 35m

In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in Waldenström macroglobulinemia, mantle cell lymphoma, Hodgkin lymphoma, and DLBCL presented at the 2020 annual meetings of the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA). Studies include:

ASPEN: Zanubrutinib vs ibrutinib in WM

OASIS: Ibrutinib, venetoclax, and obinutuzumab in MCL

GHSG HD17: PET-guided therapy in HL

KEYNOTE-024: Pembrolizumab vs brentuximab in HL

ALEXANDER: AUTO3 in DLBCL

Presenters:

Jennifer R. Brown, MD, PhD

Associate…